Electroencephalogram Monitoring Market Size, Share, & Trend Analysis - Global - 2025-2031 - Includes: EEG Monitors Market and EEG Electrodes Market
Description
Global Electroencephalogram Monitoring Market Report, 2025 Edition
Executive Summary
The global electroencephalogram (EEG) monitoring market was valued at $497 million in 2024 and is expected to grow at a 5.2 percent CAGR to reach nearly $708 million by 2032. EEG systems have become essential clinical tools in neurology, critical care, emergency medicine, and long-term epilepsy management.
This report covers EEG monitors and EEG electrodes, including disposable and reusable models. It quantifies units, average selling prices, market values, growth rates, and company shares. It evaluates the principal drivers and limiters shaping the market, offers recent M&A context, and reviews product portfolios and competitive positioning. Historical data to 2022 and forecasts to 2032 are included.
The prevalence of epilepsy remains a major global clinical challenge. According to the World Health Organization, approximately 50 million people worldwide live with epilepsy. The majority could live seizure-free with proper diagnosis and treatment. This creates a significant unmet need that directly increases demand for EEG devices, as EEG is the primary diagnostic and monitoring tool for seizure activity. Moreover, the number of epilepsy cases is growing at approximately 2 percent annually, adding sustained pressure on health systems to increase diagnostic capacity.
EEG monitoring is also expanding within intensive care units, where non-convulsive seizures often go undetected without continuous observation. As awareness of these events increases, hospitals and alternate care sites are investing more in long-term and ICU EEG systems.
This report provides comprehensive insights for clinical, commercial, and strategic stakeholders across the global EEG monitoring market.
Market Overview
Electroencephalogram monitoring measures electrical activity in the brain to diagnose and track neurological conditions. EEG systems support a wide range of clinical situations, including:
Routine diagnostic evaluations
Epilepsy diagnosis and monitoring
Critical care surveillance
Long-term epilepsy monitoring (LTM)
Sleep studies
Pre-surgical evaluation
Brain function assessment after injury
Intraoperative monitoring in select procedures
The global EEG market includes capital EEG systems and electrodes, the latter of which provide recurring revenue across both disposable and reusable formats. Rising procedural volumes in neurology, emergency medicine, and ICU settings continue to push adoption.
Several structural forces shape the global EEG market:
High epilepsy prevalence and ongoing diagnostic gaps
Increased adoption of EEG in ICUs for non-convulsive seizure detection
Rising availability of insurance coverage in multiple regions
Improvements to overall healthcare infrastructure in developing markets
Greater emphasis on continuous neuron-physiological monitoring
Strong clinical evidence supporting EEG’s role in acute and chronic neurological disorders
The market is shifting as disposable electrodes become more common, driven by infection control priorities and workflow convenience. Simultaneously, long-term EEG and ICU EEG represent two of the most important growth areas, as these settings increasingly rely on continuous monitoring, video capture, and advanced data analysis.
Despite growth opportunities, many established markets are mature and rely on replacement cycles rather than new installations. Capital purchasing budgets continue to influence the pace of adoption, particularly in lower-income regions that lack dedicated funding for neurodiagnostic equipment.
Market Drivers
Awareness of EEG as a Vital Measurement
EEG has become a central component of cerebral monitoring in both acute and sub-acute environments. Within intensive care units, EEG use continues to rise due to growing awareness of the high incidence of non-convulsive seizures that can occur without obvious clinical signs. Continuous EEG monitoring provides a stable and reliable parameter that clinicians can use to identify seizure activity, assess brain function, and guide interventions.
As more clinicians recognize the diagnostic value of EEG in critically ill patients, the demand for long-term systems, advanced software interpretation tools, and ICU-based EEG solutions increases. Awareness drives both hospital-level investment and broader integration of EEG as a standard monitoring parameter.
Prevalence of Epilepsy
Epilepsy remains one of the most common neurological conditions globally. With 50 million people affected worldwide, the disease represents a major burden on health systems. Many individuals, particularly in low and middle-income countries, lack access to diagnostic resources. EEG is the cornerstone of epilepsy diagnosis. The significant treatment gap associated with epilepsy increases demand for EEG monitors and electrodes.
With epilepsy prevalence growing at approximately 2 percent per year, new cases continue to drive upward pressure on diagnostic volumes. As more regions expand healthcare coverage and improve access to specialized care, EEG utilization will expand accordingly.
Technological Advancements
Innovation is an important driver within the EEG market. New capabilities continue to influence purchasing decisions, especially in long-term monitoring where advanced features are highly valued. Examples include:
High-definition video recording
Data trending and recall tools
Enhanced event detection software
Cloud-based storage systems
Improved electrode designs
Better signal resolution
Multi-day monitoring workflows
In regions where practice standards for ICU EEG monitoring are emerging, hospitals increasingly require systems that support long-duration monitoring with integrated video and robust data analysis. These advanced systems command higher average selling prices and drive capital purchasing activity.
Technological improvements also increase clinical efficiency. As software becomes more intuitive and automated, interpretation workflows improve and clinicians can analyze EEG data more quickly. These operational benefits support ongoing investment and make EEG more accessible to new users.
Market Limiters
Risk Management and Infection Control
Infection control requirements have significantly influenced electrode purchasing. Many countries have shifted away from reusable electrodes as hospitals aim to reduce infection risks, minimize reprocessing steps, and decrease cross-contamination possibilities. The sanitization process for reusable electrodes requires time, labor, and additional equipment, increasing total costs.
The shift to disposable electrodes is supported by some vendors that bundle electrodes with imaging or monitoring equipment. However, movement toward disposables introduces pricing pressure, as increased competition encourages suppliers to reduce costs. As a result, both reusable and disposable segments face downward pricing forces, limiting total market value.
Extended Device Life Cycle
Capital EEG systems have historically been replaced every five years in some regions. Due to limited budgets and a lack of funding dedicated to neurodiagnostic services, many hospitals extend the lifespan of existing devices to around seven years, and in lower-income regions even longer. When purchasing delays become standard practice, market growth slows and replacement cycles stretch.
Budget constraints affect both new installations and upgrades. Since EEG systems are seen as specialized devices compared with general monitoring platforms, they may receive lower priority within capital planning cycles.
Market Maturity in Key Regions
Similar to other neurodiagnostic technologies, EEG system adoption is mature in North America, Western Europe, and advanced Asia Pacific countries. Hospitals in these regions already have established EEG programs in neurology and epilepsy departments. As a result, unit sales in these regions rely heavily on replacement demand rather than new installations.
Growth opportunities exist in developing regions, but slower expansion of trained personnel, limited neurological infrastructure, and capital budget limitations moderate the pace of adoption.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Unit sales
Average selling prices
Market growth rates
Forecasts to 2032
Qualitative Coverage
Market trends and developments
Market limiters
Competitive analysis and SWOT reviews
Company profiles and product portfolios
Mergers and acquisitions
Regulatory considerations
Clinical background and disease overviews
Data Sources
Interviews with industry executives
Government physician and hospital data
Regulatory databases
Hospital procurement data
Import and export records
iData Research’s internal datasets and forecasting models
Markets Covered and Segmentation
EEG Monitoring Market by Device Type
EEG Monitors
Clinical EEG
Long-term EEG
ICU EEG
EEG Electrodes
Disposable EEG electrodes
Reusable EEG electrodes
Segmentation includes unit sales, ASPs, and revenue breakdowns for each product type across all major global regions.
Competitive Analysis
Natus Medical
Natus Medical was the clear leader in the global EEG monitoring market in 2024. The company continues to strengthen its position through strategic acquisitions and has developed a comprehensive EEG portfolio. Natus produces a wide selection of clinical, long-term, and ICU EEG systems. Its EEG electrode portfolio has historically emphasized reusable models, although reusable electrode sales stagnated in recent years due to infection control concerns.
Despite this, Natus maintained leadership within the EEG electrode segment in 2024, supported by strong brand recognition and widespread installed bases. Continued investment in advanced EEG technologies keeps Natus at the forefront of the global market.
Nihon Kohden
Nihon Kohden held the second-leading market position in 2024. The company offers both stationary and ambulatory EEG systems. Its Trackit platform includes bipolar polygraph and monopolar EEG capabilities, with CompactFlash data storage. Data can be transferred to the Polaris.one system for analysis, which supports a range of specialized software packages.
Nihon Kohden's EEG systems benefit from the company’s broader neurodiagnostic ecosystem. Integration with its EEG amplifiers and long-term monitoring solutions helps create unified clinical workflows that appeal to hospitals seeking consolidated platforms.
Ambu
Ambu was the third-leading competitor in the market in 2024. Ambu’s market share is driven primarily by its strong position in the EEG electrode segment, especially disposable products. Although electrodes represent a smaller portion of the total EEG market compared with monitor sales, Ambu’s presence in this category provides a consistent revenue base. Continued interest in disposable electrodes for infection control reinforces Ambu’s relevance.
Technology and Practice Trends
Increasing adoption of continuous EEG in ICUs
Broader use of long-term monitoring for epilepsy diagnosis and surgical evaluation
High-definition video integration in LTM systems
Enhanced software for data trending, artifact rejection, and remote interpretation
Transition from reusable to disposable electrodes for infection control
Expansion of home and ambulatory EEG as outpatient volumes increase
Growing interest in cloud-based workflows and tele-neurology
Integration with hospital electronic record systems for unified data access
These trends reflect the growing importance of EEG in both acute and chronic neurological care settings.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where are the fastest-growing opportunities in clinical EEG, LTM, and ICU EEG
How is epilepsy prevalence shaping demand across global regions
What factors influence the shift from reusable to disposable electrodes
Which technological upgrades are driving new capital equipment purchases
How do budget limitations and extended device life cycles affect the market
What competitive strategies define the leading EEG manufacturers
How can suppliers leverage pricing, segmentation, and workflow integration to expand market share
The Global Electroencephalogram Monitoring Market Report from iData Research provides detailed insights needed to quantify demand, plan product strategy, and evaluate competitive positioning in a rapidly evolving neurodiagnostic landscape.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows.
Executive Summary
The global electroencephalogram (EEG) monitoring market was valued at $497 million in 2024 and is expected to grow at a 5.2 percent CAGR to reach nearly $708 million by 2032. EEG systems have become essential clinical tools in neurology, critical care, emergency medicine, and long-term epilepsy management.
This report covers EEG monitors and EEG electrodes, including disposable and reusable models. It quantifies units, average selling prices, market values, growth rates, and company shares. It evaluates the principal drivers and limiters shaping the market, offers recent M&A context, and reviews product portfolios and competitive positioning. Historical data to 2022 and forecasts to 2032 are included.
The prevalence of epilepsy remains a major global clinical challenge. According to the World Health Organization, approximately 50 million people worldwide live with epilepsy. The majority could live seizure-free with proper diagnosis and treatment. This creates a significant unmet need that directly increases demand for EEG devices, as EEG is the primary diagnostic and monitoring tool for seizure activity. Moreover, the number of epilepsy cases is growing at approximately 2 percent annually, adding sustained pressure on health systems to increase diagnostic capacity.
EEG monitoring is also expanding within intensive care units, where non-convulsive seizures often go undetected without continuous observation. As awareness of these events increases, hospitals and alternate care sites are investing more in long-term and ICU EEG systems.
This report provides comprehensive insights for clinical, commercial, and strategic stakeholders across the global EEG monitoring market.
Market Overview
Electroencephalogram monitoring measures electrical activity in the brain to diagnose and track neurological conditions. EEG systems support a wide range of clinical situations, including:
Routine diagnostic evaluations
Epilepsy diagnosis and monitoring
Critical care surveillance
Long-term epilepsy monitoring (LTM)
Sleep studies
Pre-surgical evaluation
Brain function assessment after injury
Intraoperative monitoring in select procedures
The global EEG market includes capital EEG systems and electrodes, the latter of which provide recurring revenue across both disposable and reusable formats. Rising procedural volumes in neurology, emergency medicine, and ICU settings continue to push adoption.
Several structural forces shape the global EEG market:
High epilepsy prevalence and ongoing diagnostic gaps
Increased adoption of EEG in ICUs for non-convulsive seizure detection
Rising availability of insurance coverage in multiple regions
Improvements to overall healthcare infrastructure in developing markets
Greater emphasis on continuous neuron-physiological monitoring
Strong clinical evidence supporting EEG’s role in acute and chronic neurological disorders
The market is shifting as disposable electrodes become more common, driven by infection control priorities and workflow convenience. Simultaneously, long-term EEG and ICU EEG represent two of the most important growth areas, as these settings increasingly rely on continuous monitoring, video capture, and advanced data analysis.
Despite growth opportunities, many established markets are mature and rely on replacement cycles rather than new installations. Capital purchasing budgets continue to influence the pace of adoption, particularly in lower-income regions that lack dedicated funding for neurodiagnostic equipment.
Market Drivers
Awareness of EEG as a Vital Measurement
EEG has become a central component of cerebral monitoring in both acute and sub-acute environments. Within intensive care units, EEG use continues to rise due to growing awareness of the high incidence of non-convulsive seizures that can occur without obvious clinical signs. Continuous EEG monitoring provides a stable and reliable parameter that clinicians can use to identify seizure activity, assess brain function, and guide interventions.
As more clinicians recognize the diagnostic value of EEG in critically ill patients, the demand for long-term systems, advanced software interpretation tools, and ICU-based EEG solutions increases. Awareness drives both hospital-level investment and broader integration of EEG as a standard monitoring parameter.
Prevalence of Epilepsy
Epilepsy remains one of the most common neurological conditions globally. With 50 million people affected worldwide, the disease represents a major burden on health systems. Many individuals, particularly in low and middle-income countries, lack access to diagnostic resources. EEG is the cornerstone of epilepsy diagnosis. The significant treatment gap associated with epilepsy increases demand for EEG monitors and electrodes.
With epilepsy prevalence growing at approximately 2 percent per year, new cases continue to drive upward pressure on diagnostic volumes. As more regions expand healthcare coverage and improve access to specialized care, EEG utilization will expand accordingly.
Technological Advancements
Innovation is an important driver within the EEG market. New capabilities continue to influence purchasing decisions, especially in long-term monitoring where advanced features are highly valued. Examples include:
High-definition video recording
Data trending and recall tools
Enhanced event detection software
Cloud-based storage systems
Improved electrode designs
Better signal resolution
Multi-day monitoring workflows
In regions where practice standards for ICU EEG monitoring are emerging, hospitals increasingly require systems that support long-duration monitoring with integrated video and robust data analysis. These advanced systems command higher average selling prices and drive capital purchasing activity.
Technological improvements also increase clinical efficiency. As software becomes more intuitive and automated, interpretation workflows improve and clinicians can analyze EEG data more quickly. These operational benefits support ongoing investment and make EEG more accessible to new users.
Market Limiters
Risk Management and Infection Control
Infection control requirements have significantly influenced electrode purchasing. Many countries have shifted away from reusable electrodes as hospitals aim to reduce infection risks, minimize reprocessing steps, and decrease cross-contamination possibilities. The sanitization process for reusable electrodes requires time, labor, and additional equipment, increasing total costs.
The shift to disposable electrodes is supported by some vendors that bundle electrodes with imaging or monitoring equipment. However, movement toward disposables introduces pricing pressure, as increased competition encourages suppliers to reduce costs. As a result, both reusable and disposable segments face downward pricing forces, limiting total market value.
Extended Device Life Cycle
Capital EEG systems have historically been replaced every five years in some regions. Due to limited budgets and a lack of funding dedicated to neurodiagnostic services, many hospitals extend the lifespan of existing devices to around seven years, and in lower-income regions even longer. When purchasing delays become standard practice, market growth slows and replacement cycles stretch.
Budget constraints affect both new installations and upgrades. Since EEG systems are seen as specialized devices compared with general monitoring platforms, they may receive lower priority within capital planning cycles.
Market Maturity in Key Regions
Similar to other neurodiagnostic technologies, EEG system adoption is mature in North America, Western Europe, and advanced Asia Pacific countries. Hospitals in these regions already have established EEG programs in neurology and epilepsy departments. As a result, unit sales in these regions rely heavily on replacement demand rather than new installations.
Growth opportunities exist in developing regions, but slower expansion of trained personnel, limited neurological infrastructure, and capital budget limitations moderate the pace of adoption.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Unit sales
Average selling prices
Market growth rates
Forecasts to 2032
Qualitative Coverage
Market trends and developments
Market limiters
Competitive analysis and SWOT reviews
Company profiles and product portfolios
Mergers and acquisitions
Regulatory considerations
Clinical background and disease overviews
Data Sources
Interviews with industry executives
Government physician and hospital data
Regulatory databases
Hospital procurement data
Import and export records
iData Research’s internal datasets and forecasting models
Markets Covered and Segmentation
EEG Monitoring Market by Device Type
EEG Monitors
Clinical EEG
Long-term EEG
ICU EEG
EEG Electrodes
Disposable EEG electrodes
Reusable EEG electrodes
Segmentation includes unit sales, ASPs, and revenue breakdowns for each product type across all major global regions.
Competitive Analysis
Natus Medical
Natus Medical was the clear leader in the global EEG monitoring market in 2024. The company continues to strengthen its position through strategic acquisitions and has developed a comprehensive EEG portfolio. Natus produces a wide selection of clinical, long-term, and ICU EEG systems. Its EEG electrode portfolio has historically emphasized reusable models, although reusable electrode sales stagnated in recent years due to infection control concerns.
Despite this, Natus maintained leadership within the EEG electrode segment in 2024, supported by strong brand recognition and widespread installed bases. Continued investment in advanced EEG technologies keeps Natus at the forefront of the global market.
Nihon Kohden
Nihon Kohden held the second-leading market position in 2024. The company offers both stationary and ambulatory EEG systems. Its Trackit platform includes bipolar polygraph and monopolar EEG capabilities, with CompactFlash data storage. Data can be transferred to the Polaris.one system for analysis, which supports a range of specialized software packages.
Nihon Kohden's EEG systems benefit from the company’s broader neurodiagnostic ecosystem. Integration with its EEG amplifiers and long-term monitoring solutions helps create unified clinical workflows that appeal to hospitals seeking consolidated platforms.
Ambu
Ambu was the third-leading competitor in the market in 2024. Ambu’s market share is driven primarily by its strong position in the EEG electrode segment, especially disposable products. Although electrodes represent a smaller portion of the total EEG market compared with monitor sales, Ambu’s presence in this category provides a consistent revenue base. Continued interest in disposable electrodes for infection control reinforces Ambu’s relevance.
Technology and Practice Trends
Increasing adoption of continuous EEG in ICUs
Broader use of long-term monitoring for epilepsy diagnosis and surgical evaluation
High-definition video integration in LTM systems
Enhanced software for data trending, artifact rejection, and remote interpretation
Transition from reusable to disposable electrodes for infection control
Expansion of home and ambulatory EEG as outpatient volumes increase
Growing interest in cloud-based workflows and tele-neurology
Integration with hospital electronic record systems for unified data access
These trends reflect the growing importance of EEG in both acute and chronic neurological care settings.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where are the fastest-growing opportunities in clinical EEG, LTM, and ICU EEG
How is epilepsy prevalence shaping demand across global regions
What factors influence the shift from reusable to disposable electrodes
Which technological upgrades are driving new capital equipment purchases
How do budget limitations and extended device life cycles affect the market
What competitive strategies define the leading EEG manufacturers
How can suppliers leverage pricing, segmentation, and workflow integration to expand market share
The Global Electroencephalogram Monitoring Market Report from iData Research provides detailed insights needed to quantify demand, plan product strategy, and evaluate competitive positioning in a rapidly evolving neurodiagnostic landscape.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows.
Table of Contents
78 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
